| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | — | — |
| R&D Expense | $171.7M | — | +65.6% |
| Operating Income | -$254.6M | — | -76.8% |
| Pre-tax Income | -$217.6M | — | -133.2% |
| Income Tax | $100K | — | +0.0% |
| Net Income | -$217.7M | — | -133.1% |
| EPS (Basic) | -$0.28 | — | -64.7% |
| EPS (Diluted) | -$0.28 | — | -64.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $951.1M | -6.9% | -7.7% |
| Current Assets | $1.90B | -8.5% | +78.4% |
| Total Assets | $2.32B | -5.8% | +91.2% |
| Current Liabilities | $105.2M | +0.8% | +56.1% |
| Long-term Debt | $80.2M | -0.1% | +25.1% |
| Total Liabilities | $243.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$149.1M | — | -57.6% |
| Capital Expenditures | $32.6M | — | +226.0% |
| Investing Cash Flow | $78.7M | — | +887.0% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | -$181.7M | — | -73.7% |
| +19.7% |
| Stockholders' Equity | $2.08B | -5.6% | +105.6% |